As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of CVS Health: Jane Street Group LLC, Goldman Sachs Group Inc., Parallax Volatility Advisers L.P., Parsifal Capital Management LP, Millennium Management LLC, Cubist Systematic Strategies LLC, Royal Bank of Canada, Caption Management LLC, Nomura Holdings Inc., DRW Securities LLC, Twin Tree Management LP, Susquehanna International Group LLP, HAP Trading LLC, BNP Paribas Financial Markets, Eisler Capital Management Ltd., PEAK6 LLC, Walleye Trading LLC, Walleye Capital LLC, Capital Fund Management S.A., Maven Securities LTD, Summit Securities Group LLC, Simplex Trading LLC, JPMorgan Chase & Co., Wolverine Asset Management LLC, Citigroup Inc., LPL Financial LLC, Allianz Asset Management GmbH, Caas Capital Management LP, and Fulcrum Asset Management LLP. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.